News

Lonza’s Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC

Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studiesCollaboration underscores Lonza's commitment to...

OncoResponse to Present Phase 1 Results of Clinical Study of OR502, anti-LILRB2 Antibody, as a Late-Breaker Poster Presentation at SITC 2024

HOUSTON, Nov. 4, 2024 /PRNewswire/ -- OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of Elite Cancer...

WELL Health to Acquire Canadian Clinical Assets of Jack Nathan Health and Begin Operating Clinics in Wal-Mart Stores to Grow Healthcare Clinic Network Across Canada

Sense Neuro Diagnostics Awarded $2 Million Contract to Advance Brain Hemorrhage Detection Technology for Traumatic Brain Injury (TBI)

CINCINNATI, Nov. 4, 2024 /PRNewswire/ -- Sense Neuro Diagnostics, a leader in developing technology for the diagnosis and monitoring of brain...

error: Content is protected !!